Impact Biomedical (IBO) Current Assets (2022 - 2026)

Impact Biomedical (IBO) has reported Current Assets for 5 consecutive years, with $320000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets fell 78.39% year-over-year to $320000.0; the trailing twelve-month figure through Jun 2026 stood at $320000.0 (down 78.39% YoY), and the FY2025 full-year result was $411000.0, down 83.21% from the prior year.
• Current Assets retreated to $320000.0 in Q2 2026 per IBO's latest filing, from $377000.0 in the prior quarter.
• Across five years, Current Assets topped out at $3.2 million in Q3 2024 and bottomed at $122000.0 in Q4 2022.
• Historically, Current Assets has averaged $946928.6 across 5 years, with a median of $394000.0 in 2025.
• The sharpest annual moves came in 2024 and 2025: Current Assets soared 637.35% in 2024, then slumped 83.21% in 2025.
• Over 5 years, Current Assets stood at $122000.0 in 2022, then soared by 172.13% to $332000.0 in 2023, then jumped by 637.35% to $2.4 million in 2024, then plunged by 83.21% to $411000.0 in 2025, then dropped by 22.14% to $320000.0 in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $320000.0, $377000.0, and $411000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.